Professor Michael Kalloniatis has stepped down from the role of Centre for Eye Health (CFEH) Director. Having led the organisation for 14 years, he
A recent study suggesting that 31% of patients with neovascular age-related macular degeneration (nAMD) can safely stop eye injections is dangerously misleading.
Medicines Australia has called for a long-term vision for health with strong investments in the PBS, science and innovation to ensure faster access for
Luxturna (voretigene neparvovec, Novartis), is now funded for the treatment of patients living with an inherited retinal disease (IRD) caused by pathological biallelic RPE65
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
